TARS - Tarsus Pharmaceuticals  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TARS is currently covered by 6 analysts with an average price target of $84.3. This is a potential upside of $21.52 (34.28%) from yesterday's end of day stock price of $62.78.

Tarsus Pharmaceuticals 's activity chart (see below) currently has 64 price targets and 47 ratings on display. The stock rating distribution of TARS is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 90% with an average time for these price targets to be met of 472.67 days.

Highest price target for TARS is $88, Lowest price target is $51, average price target is $69.5.

Most recent stock forecast was given by EDDIE HICKMAN from GUGGENHEIM on 05-Nov-2025. First documented stock forecast 10-Nov-2020.

Currently out of the existing stock ratings of TARS, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Jun-2023

$87

$26.22 (43.14%)

$84

3 months 13 days ago
(05-Nov-2025)

3/5 (60%)

$18.8 (27.57%)

457

Buy Since 27-May-2025

$88

$27.22 (44.78%)

$72

3 months 29 days ago
(20-Oct-2025)

1/2 (50%)

$16.81 (23.61%)

141

Hold Since 20-Nov-2023

$51

$-9.78 (-16.09%)

$41

9 months 13 days ago
(05-May-2025)

4/4 (100%)

$3 (6.25%)

87

Buy Since 22-Jun-2021

$58

$-2.78 (-4.57%)

$45

11 months 12 days ago
(06-Mar-2025)

3/3 (100%)

$14.43 (33.12%)

477

Buy Since 21-Dec-2021

$73

$12.22 (20.11%)

$61

11 months 23 days ago
(26-Feb-2025)

10/10 (100%)

$30.44 (71.52%)

564

Show more analysts

Please expand the browser size to see the chart

What is TARS (Tarsus Pharmaceuticals ) average time for price targets to be met?

On average it took 472.67 days on average for the stock forecasts to be realized with a an average price target met ratio 90

Which analyst has the current highest performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the current lower performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?

MATTHEW CAUFIELD

Which analyst has the most public recommendations on TARS (Tarsus Pharmaceuticals )?

Francois Brisebois works at LIFESCI and has 4 price targets and 3 ratings on TARS

Which analyst is the currently most bullish on TARS (Tarsus Pharmaceuticals )?

Matthew Caufield with highest potential upside - $27.22

Which analyst is the currently most reserved on TARS (Tarsus Pharmaceuticals )?

Andrea Tan with lowest potential downside - -$9.78

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?